$BEAM
Beam Therapeutics Inc.

2021 Q4 Form 10-Q Financial Statement

#000095017021003317 Filed on November 08, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q4
Revenue $51.07M $763.0K $10.00K
YoY Change 510590.0% 12616.67% 0.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $17.77M $15.77M $8.350M
YoY Change 112.84% 110.32% 35.55%
% of Gross Profit
Research & Development $96.78M $54.62M $32.45M
YoY Change 198.25% 83.15% 60.48%
% of Gross Profit
Depreciation & Amortization $2.634M $1.675M $1.280M
YoY Change 105.78% 37.52% 28.0%
% of Gross Profit
Operating Expenses $114.6M $70.40M $40.81M
YoY Change 180.7% 88.6% 54.7%
Operating Profit -$69.63M
YoY Change 86.58%
Interest Expense -$14.51M $30.92M -$54.67M
YoY Change -73.47% 977.25% 3750.0%
% of Operating Profit
Other Income/Expense, Net $13.28M $41.52M
YoY Change 1347.05%
Pretax Income -$64.71M -$28.12M -$95.46M
YoY Change -32.22% -18.38% 242.76%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$64.71M -$28.12M -$95.46M
YoY Change -32.22% -18.38% 242.76%
Net Earnings / Revenue -126.71% -3685.19% -954600.0%
Basic Earnings Per Share -$0.42
Diluted Earnings Per Share -$951.2K -$0.42 -$1.686M
COMMON SHARES
Basic Shares Outstanding 68.14M 66.38M
Diluted Shares Outstanding 66.38M

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $965.6M $933.4M $299.7M
YoY Change 222.24% 361.62% 226.44%
Cash & Equivalents $560.0M $612.0M $162.2M
Short-Term Investments $405.7M $321.4M $137.5M
Other Short-Term Assets $7.360M $8.019M $8.700M
YoY Change -15.4% 23.37% 222.22%
Inventory
Prepaid Expenses
Receivables $300.0M
Other Receivables $0.00
Total Short-Term Assets $1.273B $941.4M $308.3M
YoY Change 312.88% 351.09% 226.11%
LONG-TERM ASSETS
Property, Plant & Equipment $84.26M $71.53M $38.51M
YoY Change 118.78% 39.71% 58.55%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $24.54M
YoY Change
Other Assets $1.724M $1.051M $3.144M
YoY Change -45.17% -94.29% -36.82%
Total Long-Term Assets $201.4M $215.1M $143.4M
YoY Change 40.52% 209.1% 132.89%
TOTAL ASSETS
Total Short-Term Assets $1.273B $941.4M $308.3M
Total Long-Term Assets $201.4M $215.1M $143.4M
Total Assets $1.474B $1.157B $451.7M
YoY Change 226.44% 315.58% 189.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.474M $7.282M $6.314M
YoY Change 18.37% 10.33% -19.53%
Accrued Expenses $75.20M $29.45M $22.70M
YoY Change 231.3% 30.31% 86.07%
Deferred Revenue $86.27M $12.82M $24.00K
YoY Change 359358.33%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.287M $2.238M $2.100M
YoY Change 8.9% 31.65% 61.54%
Total Short-Term Liabilities $213.4M $101.4M $102.3M
YoY Change 108.56% 113.45% 251.21%
LONG-TERM LIABILITIES
Long-Term Debt $3.007M $3.598M $5.300M
YoY Change -43.26% -18.23% 20.45%
Other Long-Term Liabilities $2.793M $852.0K $2.077M
YoY Change 34.47% -96.76% 396.89%
Total Long-Term Liabilities $2.793M $852.0K $2.077M
YoY Change 34.47% -97.22% 396.89%
TOTAL LIABILITIES
Total Short-Term Liabilities $213.4M $101.4M $102.3M
Total Long-Term Liabilities $2.793M $852.0K $2.077M
Total Liabilities $647.7M $302.7M $206.1M
YoY Change 214.25% 287.14% 273.71%
SHAREHOLDERS EQUITY
Retained Earnings -$768.3M -$703.6M -$397.6M
YoY Change 93.21% 95.84%
Common Stock $684.0K $677.0K $573.0K
YoY Change 19.37% 684.93%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $826.7M $853.8M $245.6M
YoY Change
Total Liabilities & Shareholders Equity $1.474B $1.157B $451.7M
YoY Change 226.44% 315.58% 189.35%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q4
OPERATING ACTIVITIES
Net Income -$64.71M -$28.12M -$95.46M
YoY Change -32.22% -18.38% 242.76%
Depreciation, Depletion And Amortization $2.634M $1.675M $1.280M
YoY Change 105.78% 37.52% 28.0%
Cash From Operating Activities $1.830M $3.007M -$24.30M
YoY Change -107.53% -114.18% 36.52%
INVESTING ACTIVITIES
Capital Expenditures -$13.37M -$5.780M -$8.130M
YoY Change 64.44% 104.96% 276.39%
Acquisitions
YoY Change
Other Investing Activities -$64.13M $81.90M -$73.31M
YoY Change -12.53% 115.23% -491.61%
Cash From Investing Activities -$77.50M $76.11M -$81.42M
YoY Change -4.82% 116.11% -591.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 21.54M 320.9M 130.0M
YoY Change -83.43% 356440.0% 18470.0%
NET CHANGE
Cash From Operating Activities 1.830M 3.007M -24.30M
Cash From Investing Activities -77.50M 76.11M -81.42M
Cash From Financing Activities 21.54M 320.9M 130.0M
Net Change In Cash -54.12M 400.0M 24.27M
YoY Change -323.0% 2736.94% -4594.44%
FREE CASH FLOW
Cash From Operating Activities $1.830M $3.007M -$24.30M
Capital Expenditures -$13.37M -$5.780M -$8.130M
Free Cash Flow $15.20M $8.787M -$16.17M
YoY Change -194.0% -147.78% 3.39%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Transition Report
DocumentTransitionReport
false
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q3 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
beam:LicenseAndCollaborationRevenueMember
CY2021Q3 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
beam:LicenseAndCollaborationRevenueMember
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001745999
CY2018Q4 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
us-gaap:AccountingStandardsUpdate201701Member
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
beam:LicenseAndCollaborationRevenueMember
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
beam:LicenseAndCollaborationRevenueMember
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity File Number
EntityFileNumber
001-39208
dei Entity Registrant Name
EntityRegistrantName
Beam Therapeutics Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-5238376
dei Entity Address Address Line1
EntityAddressAddressLine1
26 Landsdowne Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Cambridge
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02139
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.69
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.69
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.86
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.86
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.31
CY2021Q3 beam Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
22965000
CY2020Q4 beam Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
18463000
CY2021Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
49600000
CY2020Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
71200000
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
12822000
dei City Area Code
CityAreaCode
857
dei Local Phone Number
LocalPhoneNumber
327-8775
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
BEAM
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
68135798
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
612023000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
162171000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
321382000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
137500000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8019000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8650000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
941424000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
308321000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
71533000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
38513000
CY2021Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
14840000
CY2020Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
14840000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
103169000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
86859000
CY2021Q3 us-gaap Long Term Investments
LongTermInvestments
24538000
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
2577000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1051000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
567000
CY2021Q3 us-gaap Assets
Assets
1156555000
CY2020Q4 us-gaap Assets
Assets
451677000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
7282000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6314000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
24000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6484000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4218000
CY2021Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2238000
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2118000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
101391000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-703567000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-397636000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
853814000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
245561000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1156555000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
451677000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
763000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
102337000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
133120000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
96014000
CY2021Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
3598000
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
5294000
CY2021Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
26960000
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0
CY2021Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
36820000
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
394000
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
852000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2077000
CY2021Q3 us-gaap Liabilities
Liabilities
302741000
CY2020Q4 us-gaap Liabilities
Liabilities
206116000
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
68126713
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
58446016
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
67734484
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
57254178
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
677000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
573000
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1556685000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
642633000
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
19000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-9000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
775000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
54623000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
29825000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
290306000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
70728000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15774000
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7502000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
39450000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21251000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
70397000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
37327000
us-gaap Operating Expenses
OperatingExpenses
329756000
us-gaap Operating Expenses
OperatingExpenses
91979000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-69634000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-37321000
us-gaap Operating Income Loss
OperatingIncomeLoss
-328981000
us-gaap Operating Income Loss
OperatingIncomeLoss
-91961000
CY2021Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
35800000
CY2020Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
2700000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-8400000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-8700000
CY2021Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-4892000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
21960000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
517000
CY2021Q3 beam Change In Fair Value Of Contingent Consideration Liabilities
ChangeInFairValueOfContingentConsiderationLiabilities
-10599000
beam Change In Fair Value Of Contingent Consideration Liabilities
ChangeInFairValueOfContingentConsiderationLiabilities
-9553000
CY2021Q3 beam Interest And Other Income Expense Net
InterestAndOtherIncomeExpenseNet
9000
CY2020Q3 beam Interest And Other Income Expense Net
InterestAndOtherIncomeExpenseNet
169000
beam Interest And Other Income Expense Net
InterestAndOtherIncomeExpenseNet
-63000
beam Interest And Other Income Expense Net
InterestAndOtherIncomeExpenseNet
1016000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
41516000
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2869000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
23050000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7167000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-28118000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-34452000
us-gaap Net Income Loss
NetIncomeLoss
-305931000
us-gaap Net Income Loss
NetIncomeLoss
-99128000
CY2021Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-12000
CY2020Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-132000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
28000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
25000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28130000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-34584000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-305903000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-99103000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-28118000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-34452000
us-gaap Net Income Loss
NetIncomeLoss
-305931000
us-gaap Net Income Loss
NetIncomeLoss
-99128000
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
1277000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28118000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-34452000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-305931000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-100405000
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.31
CY2021Q2 beam Stock Issued During Period Value Success Payment Liability
StockIssuedDuringPeriodValueSuccessPaymentLiability
30000000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10452000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4083000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
55000
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
157785000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
422429000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
66377611
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
66377611
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50087747
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50087747
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62960219
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62960219
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43438919
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43438919
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-201104000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
1277000
CY2020Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
303326000
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
188323000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2792000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
152000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-360000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-30458000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
261394000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2769000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
360000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
517000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-34218000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
230822000
CY2020Q3 beam Issuance Of Common Stock Value Related To License Agreement
IssuanceOfCommonStockValueRelatedToLicenseAgreement
264000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3012000
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
557000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-132000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-34452000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
200071000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
245561000
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
252005000
CY2021Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
120032000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4648000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1758000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-15000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-201560000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-76253000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
548551000
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
318609000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12968000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1816000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-12000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-28118000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3463000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
28000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-49000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
606746000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
167094000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
192510000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
737205000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
8688000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1717000
beam Proceeds From Finance Lease
ProceedsFromFinanceLease
1625000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1576000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1158000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
422920000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
157380000
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
620000
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
750000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-216648000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
853814000
us-gaap Profit Loss
ProfitLoss
-305931000
us-gaap Profit Loss
ProfitLoss
-99128000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4817000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18696000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-68098000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-71443000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
33442000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8232000
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
154953000
us-gaap Share Based Compensation
ShareBasedCompensation
28068000
us-gaap Share Based Compensation
ShareBasedCompensation
8573000
beam Change In Operating Lease Right Of Use Assets
ChangeInOperatingLeaseRightOfUseAssets
6781000
beam Change In Operating Lease Right Of Use Assets
ChangeInOperatingLeaseRightOfUseAssets
3065000
beam Non Cash Research And Development License Expense Net
NonCashResearchAndDevelopmentLicenseExpenseNet
5164000
beam Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
8400000
beam Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
8700000
beam Change In Fair Value Of Contingent Consideration Liabilities
ChangeInFairValueOfContingentConsiderationLiabilities
-9553000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
21960000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
517000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-63000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-733000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3667000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
197000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
56000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1341000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-134000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2818000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
4219000
beam Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
15208000
beam Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-3249000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
49224000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-153000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
2075000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7657000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1069000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
734598000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
192329000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
449852000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
102190000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
177011000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50553000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
626863000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
152743000
us-gaap Interest Paid Net
InterestPaidNet
443000
us-gaap Interest Paid Net
InterestPaidNet
422000
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
303326000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
7515000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2809000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
24164000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
5795000
us-gaap Stock Issued1
StockIssued1
264000
beam Equity Issuance Costs In Accounts Payable And Accrued Expenses
EquityIssuanceCostsInAccountsPayableAndAccruedExpenses
118000
beam Equity Issuance Costs In Accounts Payable And Accrued Expenses
EquityIssuanceCostsInAccountsPayableAndAccruedExpenses
342000
beam Fair Value Of Common Shares Issued To Settle Success Payment Liability
FairValueOfCommonSharesIssuedToSettleSuccessPaymentLiability
30000000
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
36513000
beam Fair Value Of Equity Instruments Issued In Connection With Asset Acquisition
FairValueOfEquityInstrumentsIssuedInConnectionWithAssetAcquisition
120032000
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
1277000
CY2020Q4 beam Gross Proceeds From Issuance Of Common Stock
GrossProceedsFromIssuanceOfCommonStock
135100000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-703600000
CY2021Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
933400000
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
85055000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
47412000
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13522000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8899000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
71533000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
38513000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and expenses, the determination of the fair value equity instruments and intangible assets acquired in an asset acquisition, and the disclosure of contingent assets and liabilities as of and during the reporting period. The Company bases its estimates and assumptions on historical experience, when available, and on various factors that it believes to be reasonable under the circumstances. The Company evaluates its estimates and assumptions on an ongoing basis. Actual results could differ from these estimates.</span></p>
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
612023000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
137903000
CY2021Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
14840000
CY2020Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
14840000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
626863000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
152743000
CY2018Q4 us-gaap Change In Accounting Principle Accounting Standards Update Adopted
ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted
true
CY2021Q3 us-gaap Depreciation
Depreciation
1675000
CY2020Q3 us-gaap Depreciation
Depreciation
1218000
us-gaap Depreciation
Depreciation
4642000
us-gaap Depreciation
Depreciation
3463000
CY2021Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
321363000
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
26000
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
7000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
321382000
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
137509000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
13000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
22000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
137500000
us-gaap Debt Securities Available For Sale Realized Gain Loss Excluding Other Than Temporary Impairment
DebtSecuritiesAvailableForSaleRealizedGainLossExcludingOtherThanTemporaryImpairment
0
us-gaap Debt Securities Available For Sale Realized Gain Loss Excluding Other Than Temporary Impairment
DebtSecuritiesAvailableForSaleRealizedGainLossExcludingOtherThanTemporaryImpairment
0
beam Debt Securities Available For Sale Maturity Period
DebtSecuritiesAvailableForSaleMaturityPeriod
less than one year
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5841000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7591000
CY2021Q3 beam Accrued Research Costs
AccruedResearchCosts
4987000
CY2020Q4 beam Accrued Research Costs
AccruedResearchCosts
2423000
CY2021Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3733000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1948000
CY2021Q3 beam Accrued Process Development And Manufacturing Costs
AccruedProcessDevelopmentAndManufacturingCosts
3285000
CY2020Q4 beam Accrued Process Development And Manufacturing Costs
AccruedProcessDevelopmentAndManufacturingCosts
2272000
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5119000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4229000
CY2021Q3 beam Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
22965000
CY2020Q4 beam Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
18463000
CY2020Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
2014000
us-gaap Operating Lease Payments
OperatingLeasePayments
7053000
us-gaap Operating Lease Payments
OperatingLeasePayments
5132000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
24164000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
5795000
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
4557000
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1644000
us-gaap Operating Lease Cost
OperatingLeaseCost
13660000
us-gaap Operating Lease Cost
OperatingLeaseCost
4946000
CY2021Q3 us-gaap Variable Lease Cost
VariableLeaseCost
588000
CY2020Q3 us-gaap Variable Lease Cost
VariableLeaseCost
249000
us-gaap Variable Lease Cost
VariableLeaseCost
1162000
us-gaap Variable Lease Cost
VariableLeaseCost
786000
CY2021Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
383000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
761000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
0
CY2021Q3 us-gaap Lease Cost
LeaseCost
5528000
CY2020Q3 us-gaap Lease Cost
LeaseCost
1893000
us-gaap Lease Cost
LeaseCost
15583000
us-gaap Lease Cost
LeaseCost
5732000
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P11Y4M24D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P11Y6M
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.071
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.074
CY2021Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
3058000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
4159000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
16616000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
17262000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
17787000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
18260000
CY2021Q3 beam Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
132835000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
206919000
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
67315000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
139604000
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 beam Gross Proceeds From Issuance Of Common Stock
GrossProceedsFromIssuanceOfCommonStock
135100000
us-gaap Common Stock Voting Rights
CommonStockVotingRights
The holders of the Company’s common stock are entitled to one vote for each share of common stock.
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12968000
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3012000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
28068000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8573000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5336441
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.70
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1638143
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
88.57
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
774352
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
9.89
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
60982
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
28.53
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6139250
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
30.53
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2008588
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
9.57
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
58.85
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7426084
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7125688
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28118000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-34452000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-305931000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-100405000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
66377611
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
66377611
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50087747
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50087747
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62960219
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62960219
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43438919
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43438919
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.69
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.69
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.86
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.86
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.31
beam Number Of Founder Shareholders
NumberOfFounderShareholders
3

Files In Submission

Name View Source Status
0000950170-21-003317-index-headers.html Edgar Link pending
0000950170-21-003317-index.html Edgar Link pending
0000950170-21-003317.txt Edgar Link pending
0000950170-21-003317-xbrl.zip Edgar Link pending
beam-20210930.htm Edgar Link pending
beam-20210930.xsd Edgar Link pending
beam-20210930_cal.xml Edgar Link unprocessable
beam-20210930_def.xml Edgar Link unprocessable
beam-20210930_htm.xml Edgar Link completed
beam-20210930_lab.xml Edgar Link unprocessable
beam-20210930_pre.xml Edgar Link unprocessable
beam-ex31_1.htm Edgar Link pending
beam-ex31_2.htm Edgar Link pending
beam-ex32_1.htm Edgar Link pending
beam-ex32_2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending